EDIT Message Board Post 9190990 | Editas Medicine Inc.
home / stock / edit / edit message board
oktral
(investorshub)
Posted on: Aug/21/2021 01:10:12
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165555554
Cancer is highly complex, so multiplexed gene editing
News, Short Squeeze, Breakout and More Instantly...
-
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...
-
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a clinical-stage gene editing company, today announced t...
-
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET to discuss results for the first quarter 2024 a...